Conference Coverage

Anticoagulation not routinely needed after TAVR: ADAPT-TAVR

Publish date: April 4, 2022

 

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Mixed results for cardiologists in stroke thrombectomy
MDedge Emergency Medicine
AHA targets ‘low-value’ heart care in new scientific statement
MDedge Emergency Medicine
New data explore risk of magnetic interference with implantable devices
MDedge Emergency Medicine
Death of pig heart transplant patient is more a beginning than an end
MDedge Emergency Medicine
Congress opens investigation into FDA’s handling of a problematic heart device
MDedge Emergency Medicine
Surgery groups push back on VARC-3 valve trial definitions
MDedge Emergency Medicine
POISE-3 backs wider use of tranexamic acid in noncardiac surgery 
MDedge Emergency Medicine
FAME 3 subanalysis adds twist to negative primary results
MDedge Emergency Medicine
New HF guidelines feature ‘quad’ therapy, tweaked terminology
MDedge Emergency Medicine
Early PCSK9 inhibition in AMI yields plaque regression
MDedge Emergency Medicine